Karin Von Wnuck Lipinski
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: August 18, 2023
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Aggravates Atherosclerosis and Induces Plaque Rupture in ApoE-/-Mice.
Journal: International journal of molecular sciences
Published: July 05, 2022
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 09, 2021
Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.
Journal: Bone
Published: January 16, 2019
Targeting sphingosine-1-phosphate lyase as an anabolic therapy for bone loss.
Journal: Nature medicine
Published: January 11, 2017
Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 16, 2015
Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin.
Journal: Nature communications
Published: September 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026